Improving access to acute stroke therapies: A controlled trial of organised pre-hospital and emergency care

Medical Journal of Australia

Volumn 189, Issue 8, 2008, Pages 429-433

  Quain, Debbie A ^a,b   Parsons, Mark W ^a,b,c   Loudfoot, Allan R ^d   Spratt, Neil J ^a,c   Evans, Malcolm K ^a   Russell, Michelle L ^a   Royan, Angela T ^a   Moore, Andrea G ^a   Miteff, Ferdinand ^a,b   Hullick, Carolyn J ^b   Attia, John ^a,c   McElduff, Patrick ^a,c   Levi, Christopher R ^a,b  

^a HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d Greater Sydney Area Helicopter Emergency Medical Service Ambulance Service New South Wales Rescue Helicopter Base Bankstown Airport   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; AMBULANCE; ARTICLE; AUSTRALIA; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FEMALE; FIBRINOLYTIC THERAPY; HEALTH CARE ACCESS; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; STROKE; THERAPY DELAY; TREATMENT OUTCOME;

EID: 56349115849     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2008.tb02114.x     Document Type: Article

References (28)

1. Cadilhac DA, Lalor EE, Pearce DC, et al. Access to stroke care units in Australian public hospitals: facts and temporal progress. Intern Med J 2006; 36: 700-704.
2. Crimmins D, Bladin C, Lalor E. Clinical guidelines for acute stroke management 2007. Melbourne: National Stroke Foundation, 2007.
3. Hack W, Kaste M, Bogousslavsky J, et al. European Stroke Initiative Recommendations for Stroke Management - update 2003. Cerebrovasc Dis 2003; 16: 311-337.
4. Moodie ML, Carter R, Mihalopoulos C, et al. Trial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORU-COS) to assist priority setting in stroke. Stroke 2004; 35: 1041-1046.
5. Fagan SC, Morgenstern LB, Petitta A, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology 1998; 50: 883-890.
6. Sandercock P, Berge E, Dennis M, et al. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs. Stroke 2004; 35: 1490-1497.
7. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-1587.
8. Bray JE, Coughlan K, Bladin C. Thrombolytic therapy for acute ischaemic stroke: successful implementation in an Australian tertiary hospital. Intern Med J 2006; 36: 483-488.
9. Randahawa D. National stroke audit organisational repor acute services 2007. Melbourne: National Stroke Foundation, 2007: 6-8.
10. Qureshi AI, Fareed K, Nasar A, et al. Thrombolysis for ischemic stroke in the United States: data from national hospital discharge survey 1999-2001. Neurosurgery 2005; 57: 647-654.
11. McCormick M, Baird M, Bone I, Muir K. Implementation of stroke thrombolysis in the United Kingdom. Glasgow: University of Glasgow, 2006.
12. Grotta JC, Burgin WS, El-Mitwalli A, et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol 2001; 58: 2009-2013.
13. Schmulling S, Grond M, Rudolf J, Heiss W. One-year follow-up in acute stroke patients treated with rtPA in clinical routine. Stroke 2000; 31: 1552-1554.
14. Wojner-Alexandrov AW, Rodriguez D, Persse D, et al. Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke 2005; 36: 1512-1518.
15. Kidwell CS, Starkman S, Eckstein M, et al. Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS). Stroke 2000; 31: 71-76.
16. Harbison J, Hossain O, Jenkinson D, et al. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke 2003; 34: 71-76.
17. Weir CJ, Murray GD, Dyker AG, et al. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study. BMJ 1997; 314: 1303-1306.
18. Bonita R, Beaglehole R, Modification of Rankin Scale: recovery of motor function after stroke. Stroke 1988; 19: 1497-1500.
19. Rankin J. Cerebral vascular accidents in patients over the age of 60. I. General considerations. Scott Med J 1957; 2: 127-136.
20. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369: 275-282.
21. Szoeke CEI, Parsons MW, Butcher KS, et al. Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital. Med J Aust 2003; 178: 324-328.
22. Batmanian JJ, Lam M, Matthews C, et al. A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department. Med J Aust 2007; 187: 567-570.
23. Lindsberg PJ, Happola O, Kallela M, et al. Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology 2006; 67: 334-336.
24. Bray JE, Martin J, Cooper G, et al. An interventional study to improve paramedic diagnosis of stroke. Prehosp Emerg Care 2005; 9: 297-302.
25. Morris DL, Rosamond W, Madden K, et al. Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey. Stroke 2000; 31: 2585-2590.
26. Rajajee V, Saver J. Prehospital care of the acute stroke patient. Tech Vasc Interv Radiol 2005; 8: 74-80.
27. Tilley BC, Lyden PD, Brott TG, et al. Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Arch Neurol 1997; 54: 1466-1474.
28. National Health Priority Action Council. National Service Improvement Framework for Heart, Stroke, and Vascular Disease. Canberra: Australian Government Department of Health and Ageing, 2006: 115.